NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Davide Campari-Milano N.V (MI: CPR)
CPR Technical Analysis
5
As on 22nd Nov 2024 CPR STOCK Price closed @ 5.61 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 10.65 & Strong Sell for SHORT-TERM with Stoploss of 12.34 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CPRSTOCK Price
Open | 5.62 | Change | Price | % |
High | 5.64 | 1 Day | 0.03 | 0.54 |
Low | 5.55 | 1 Week | -0.28 | -4.75 |
Close | 5.61 | 1 Month | -1.63 | -22.51 |
Volume | 5230789 | 1 Year | -7.24 | -56.34 |
52 Week High 12.93 | 52 Week Low 5.66 |
MI Italy Most Active Stocks
TIT | 0.23 | 0.00% |
ISP | 3.63 | -1.09% |
SPM | 2.40 | 1.27% |
ENEL | 6.72 | 2.13% |
RN | 0.02 | 0.00% |
TITR | 0.27 | 0.00% |
BPE | 5.84 | -1.52% |
BMPS | 5.93 | -1.00% |
BAMI | 6.64 | -1.34% |
STLA | 15.58 | 0.45% |
MI Italy Top Gainers Stocks
MI Italy Top Losers Stocks
CPR Daily Charts |
CPR Intraday Charts |
Whats New @ Bazaartrend |
CPR Free Analysis |
|
CPR Important Levels Intraday
RESISTANCE | 5.78 |
RESISTANCE | 5.73 |
RESISTANCE | 5.69 |
RESISTANCE | 5.66 |
SUPPORT | 5.56 |
SUPPORT | 5.53 |
SUPPORT | 5.49 |
SUPPORT | 5.44 |
CPR Forecast November 2024
4th UP Forecast | 8.33 |
3rd UP Forecast | 7.46 |
2nd UP Forecast | 6.92 |
1st UP Forecast | 6.38 |
1st DOWN Forecast | 4.84 |
2nd DOWN Forecast | 4.3 |
3rd DOWN Forecast | 3.76 |
4th DOWN Forecast | 2.89 |
CPR Weekly Forecast
4th UP Forecast | 6.48 |
3rd UP Forecast | 6.20 |
2nd UP Forecast | 6.03 |
1st UP Forecast | 5.86 |
1st DOWN Forecast | 5.36 |
2nd DOWN Forecast | 5.19 |
3rd DOWN Forecast | 5.02 |
4th DOWN Forecast | 4.74 |
CPR Forecast2024
4th UP Forecast | 19.89 |
3rd UP Forecast | 15.31 |
2nd UP Forecast | 12.48 |
1st UP Forecast | 9.65 |
1st DOWN Forecast | 1.57 |
2nd DOWN Forecast | -1.26 |
3rd DOWN Forecast | -4.09 |
4th DOWN Forecast | -8.67 |
Davide Campari-Milano N.V ( MI Italy Symbol : CPR )
Sector : Consumer Defensive And Other Stocks in Same Sector
Sector : Consumer Defensive And Other Stocks in Same Sector
CPR Other Details
Segment | EQ | |
Market Capital | 13992783872.00 | |
Sector | Consumer Defensive | |
Industry | Beverages-Wineries & Distilleries | |
Offical website | > echo $website ; ?> |
CPR Address
CPR Latest News
CPR Business Profile
Davide Campari-Milano N.V., together with its subsidiaries, markets and distributes alcoholic and non-alcoholic beverages in the Americas, the Middle East, Africa, Europe, and the Asia-Pacific. It offers range of spirits categories, including aperitif, vodka, liqueurs, bitters, whisky, tequila, rum, gin, and cognac, as well as champagne and non-alcoholic aperitif under approximately 50 brands, such as Aperol, Campari, SKYY, Wild Turkey, Grand Marnier, Appleton Estate, Wray & Nephew Overproof, and other brands. The company was founded in 1860 and is headquartered in Sesto San Giovanni, Italy. Davide Campari-Milano N.V. is a subsidiary of Lagfin S.C.A., Société en Commandite par Actions. Address: Via Franco Sacchetti 20, Sesto San Giovanni, MI, Italy, 20099
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service